Detalles de la búsqueda
1.
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules.
PLoS Med
; 21(6): e1004375, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38829821
2.
An evaluation of the quality of ear health services for Aboriginal children living in remote Australia: a cascade of care analysis.
BMC Health Serv Res
; 23(1): 1186, 2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37907905
3.
Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.
BMC Pediatr
; 21(1): 117, 2021 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33685411
4.
The impact of hearing impairment on early academic achievement in Aboriginal children living in remote Australia: a data linkage study.
BMC Public Health
; 20(1): 1521, 2020 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33028291
5.
Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.
BMC Pediatr
; 15: 162, 2015 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26482232
6.
Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules.
BMC Pediatr
; 14: 200, 2014 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25109288
7.
Association between early bacterial carriage and otitis media in Aboriginal and non-Aboriginal children in a semi-arid area of Western Australia: a cohort study.
BMC Infect Dis
; 12: 366, 2012 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-23256870
8.
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials.
Lancet Infect Dis
; 22(9): 1374-1387, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35772449
9.
A community-based service enhancement model of training and employing Ear Health Facilitators to address the crisis in ear and hearing health of Aboriginal children in the Northern Territory, the Hearing for Learning Initiative (the HfLI): study protocol for a stepped-wedge cluster randomised trial.
Trials
; 22(1): 403, 2021 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34134736
10.
Randomised clinical trial research within Aboriginal and Torres Strait Islander primary health services: a qualitative study.
BMJ Open
; 11(12): e050839, 2021 12 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34952874
11.
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.
Vaccine X
; 7: 100086, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33681756
12.
Hearing loss among Australian Aboriginal infants and toddlers: A systematic review.
Public Health Pract (Oxf)
; 1: 100048, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36101696
13.
10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial.
BMJ Open
; 10(5): e033511, 2020 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32448790
14.
Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination.
BMC Pediatr
; 9: 14, 2009 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-19228431
15.
A comparison of flocked nylon swabs and non-flocked rayon swabs for detection of respiratory bacteria in nasopharyngeal carriage in Australian Indigenous children.
J Microbiol Methods
; 157: 47-49, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30578888
16.
Use of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) in an Australian Indigenous paediatric population does not alter the prevalence of nontypeable Haemophilus influenzae without the protein D gene.
Vaccine
; 37(30): 4089-4093, 2019 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31164306
17.
The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis.
BMJ Open
; 9(11): e032549, 2019 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31727664
18.
Povidone-iodine ear wash and oral cotrimoxazole for chronic suppurative otitis media in Australian aboriginal children: study protocol for factorial design randomised controlled trial.
BMC Pharmacol Toxicol
; 20(1): 46, 2019 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31351491
19.
Comparison of nasal swabs with nose blowing for community-based pneumococcal surveillance of healthy children.
J Clin Microbiol
; 46(6): 2081-2, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18385438
20.
Random colony selection versus colony morphology for detection of multiple pneumococcal serotypes in nasopharyngeal swabs.
Pediatr Infect Dis J
; 27(2): 178-80, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18174871